Thompson Siegel & Walmsley’s Ambev ABEV Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,272	Closed	-$40K	–	839
2017 Q2	$40K	Buy	+7,272	New	+$41.5K	﹤0.01%	563

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $5.27B AUM 41.17% 1-Year Est. Return

Thompson Siegel & Walmsley's ABEV Position: Q3 2017 in Review

Thompson Siegel & Walmsley sold out of Ambev (ABEV) in Q3 2017, closing a stake of 7,272 shares — an estimated $40K sold.

Thompson Siegel & Walmsley first reported a position in ABEV in Q2 2017 and held it in 1 quarter. The position peaked at $40K in Q2 2017. 312 funds tracked by Wall St. Rank hold ABEV as of Q3 2017.

Thompson Siegel & Walmsley reported no remaining Ambev position as of Q3 2017 after selling out during the quarter.
Thompson Siegel & Walmsley sold 7,272 Ambev shares in Q3 2017, an estimated $40K.
Thompson Siegel & Walmsley first reported a position in Ambev in Q2 2017 and held it in 1 quarter.
Thompson Siegel & Walmsley's Ambev position peaked at $40K in Q2 2017.
312 funds tracked by Wall St. Rank held Ambev as of Q3 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2017, filed 8 Nov 2017.